Ikena Oncology, Inc. (IKNA)
USD 1.55
(-4.32%)
USD 1.55
(-4.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.16 Million | 15.61 Million | 30.98 Million | 9.19 Million | 13.75 Million | 990 Thousand |
| Cost of Revenue | 59.65 Million | 2.03 Million | 47.1 Million | 44.84 Million | 24.93 Million | 38.98 Million |
| Gross Profit | -50.49 Million | 13.58 Million | -16.12 Million | -35.65 Million | -11.18 Million | -37.99 Million |
| Operating Expenses | 84.57 Million | 86.52 Million | 65.12 Million | 53.71 Million | 32.24 Million | 41.46 Million |
| Selling, General and Administrative Expenses | 24.92 Million | 22.2 Million | 18.01 Million | 8.86 Million | 7.3 Million | 2.89 Million |
| Research and Development Expenses | 59.65 Million | 64.32 Million | 47.1 Million | 44.84 Million | 24.93 Million | 38.56 Million |
| Other Expenses | - | -10 Thousand | 23 Thousand | 263 Thousand | 1.67 Million | - |
| Cost and Expenses | 84.57 Million | 86.52 Million | 65.12 Million | 53.71 Million | 32.24 Million | 41.88 Million |
| Operating Income | -75.41 Million | -70.9 Million | -34.13 Million | -44.51 Million | -18.49 Million | -40.89 Million |
| Interest Expense | - | 2.14 Million | - | - | - | - |
| Income Tax Expense | -162 Thousand | -2.13 Million | 307.44 Thousand | 93.7 Thousand | 71.14 Thousand | - |
| Earnings before Tax | -68.32 Million | -68.76 Million | -34.11 Million | -44.25 Million | -16.81 Million | -40.86 Million |
| Net Income | -68.16 Million | -66.62 Million | -34.11 Million | -44.25 Million | -16.81 Million | -40.86 Million |
| Earnings Per Share Basic | -1.63 | -1.84 | -0.95 | -1.23 | -0.47 | -1.14 |
| Earnings Per Share Diluted | -1.63 | -1.84 | -0.95 | -1.23 | -0.47 | -1.14 |
| Weighted Average Shares Outstanding | 41.73 Million | 36.18 Million | 35.97 Million | 35.85 Million | 35.85 Million | 35.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.73 Million | 36.18 Million | 35.97 Million | 35.85 Million | 35.85 Million | 35.85 Million |
| Gross Margin | -5.51 | 0.87 | -0.52 | -3.88 | -0.81 | -38.38 |
| EBIT Margin | -8.12 | -4.49 | -1.08 | -4.81 | -1.33 | -40.88 |
| Profit Margin | -7.44 | -4.27 | -1.10 | -4.81 | -1.22 | -41.28 |
| EBITDA | -74.39 Million | -70.15 Million | -33.59 Million | -44.21 Million | -18.24 Million | -40.44 Million |
| Earnings Before Tax Margin | -8.23 | -4.54 | -1.10 | -4.84 | -1.34 | -41.31 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 9.16 Million | 659 Thousand | 1.18 Million | 2 Million |
| Cost of Revenue | 92 Thousand | 219 Thousand | 1.02 Million | 305 Thousand | 242 Thousand | 586 Thousand |
| Gross Profit | -92 Thousand | -219 Thousand | 8.14 Million | 354 Thousand | 943 Thousand | 1.41 Million |
| Operating Expenses | 15.04 Million | 15.42 Million | 83.55 Million | 22.26 Million | 20.68 Million | 20.49 Million |
| Selling, General and Administrative Expenses | 5.3 Million | 5.99 Million | - | 8.29 Million | 6.03 Million | 5.32 Million |
| Research and Development Expenses | 9.74 Million | 9.42 Million | - | 13.96 Million | 1.18 Million | 15.17 Million |
| Other Expenses | 235 Thousand | -7000.00 | -22 Thousand | -14 Thousand | 13.46 Million | -6000.00 |
| Cost and Expenses | 15.14 Million | 15.64 Million | 84.57 Million | 22.56 Million | 20.68 Million | 20.49 Million |
| Operating Income | -15.14 Million | -15.64 Million | -75.41 Million | -21.9 Million | -19.5 Million | -18.49 Million |
| Interest Expense | - | - | - | 1.29 Million | - | - |
| Income Tax Expense | 62 Thousand | 27 Thousand | -162 Thousand | -162 Thousand | -242 Thousand | -1.38 Million |
| Earnings before Tax | -13.66 Million | -16.11 Million | -68.32 Million | -19.65 Million | -17.34 Million | -17.11 Million |
| Net Income | -13.73 Million | -16.14 Million | -68.16 Million | -19.48 Million | -17.34 Million | -17.11 Million |
| Earnings Per Share Basic | -0.28 | -0.33 | - | -0.41 | -0.40 | -0.44 |
| Earnings Per Share Diluted | -0.28 | -0.33 | - | -0.41 | -0.40 | -0.44 |
| Weighted Average Shares Outstanding | 48.25 Million | 48.25 Million | 41.73 Million | 47.8 Million | 43.43 Million | 39.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.25 Million | 48.25 Million | 41.73 Million | 47.8 Million | 43.43 Million | 39.29 Million |
| Gross Margin | - | - | 0.89 | 0.54 | 0.80 | 0.71 |
| EBIT Margin | - | - | - | -32.78 | -16.46 | -9.79 |
| Profit Margin | - | - | -7.44 | -29.57 | -14.64 | -8.54 |
| EBITDA | -15.04 Million | -15.42 Million | - | -21.6 Million | -19.5 Million | -19.62 Million |
| Earnings Before Tax Margin | - | - | -8.23 | -33.24 | -16.46 | -9.23 |
4435
FDUS
4420
ARR
TOTS3
NBSTU